- Report
- February 2026
- 276 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- February 2026
- 196 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- February 2026
- 246 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- February 2026
- 196 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- February 2026
- 363 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- February 2026
- 258 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- February 2026
- 277 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- February 2026
- 276 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- February 2026
- 277 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- February 2026
- 354 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- February 2026
- 196 Pages
Global
From €5126EUR$5,850USD£4,486GBP
- Report
- August 2025
- 189 Pages
Global
From €3106EUR$3,545USD£2,718GBP
€3452EUR$3,939USD£3,020GBP
- Report
- May 2025
- 114 Pages
Global
From €4162EUR$4,750USD£3,642GBP
- Report
- May 2025
- 110 Pages
Global
From €4162EUR$4,750USD£3,642GBP
- Report
- May 2025
- 118 Pages
Global
From €4162EUR$4,750USD£3,642GBP
- Report
- August 2025
- 120 Pages
Global
From €3504EUR$3,999USD£3,066GBP
- Report
- August 2025
- 133 Pages
Global
From €3504EUR$3,999USD£3,066GBP
- Report
- September 2025
- 150 Pages
Global
From €3417EUR$3,900USD£2,991GBP
- Report
- May 2025
- 120 Pages
Global
From €4162EUR$4,750USD£3,642GBP
- Report
- January 2026
- 125 Pages
Global
From €4162EUR$4,750USD£3,642GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more